Repligen Corporation to Present at Wells Fargo Healthcare Conference

Company Overview - Repligen Corporation is a global life sciences company focused on developing and commercializing innovative bioprocessing technologies and systems that enhance the manufacturing efficiency of biological drugs [3] - The company primarily serves biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide [3] - Key focus areas include Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [3] - Corporate headquarters are located in Waltham, Massachusetts, with manufacturing sites in the U.S. and additional locations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [3] Upcoming Events - Repligen Corporation will present at the Wells Fargo Healthcare Conference from September 4-6, 2024, in Boston [1] - Olivier Loeillot, President and CEO, will participate in an analyst-led discussion on September 6 at 8:45 a.m. ET [1] - A live webcast of the conference presentation will be available on Repligen's Investor Relations website and will be accessible for replay for a limited time after the event [2]